Novel tumor suppressive function of Smad4 in serum starvation-induced cell death through PAK1-PUMA pathway

S-H Lee1, Y-S Jung, J-Y Chung

  • 1Department of Molecular Biology, College of Natural Science, Pusan National University, Busan, Republic of Korea.

Cell Death & Disease
|December 2, 2011
PubMed

Insights

Loss of Smad4 (deleted in pancreatic cancer 4) confers resistance to serum deprivation-induced cell death. Smad4 promotes apoptosis via PUMA induction and PAK1 suppression, revealing a novel tumor-suppressive role independent of TGF-β signaling.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • Smad4 (deleted in pancreatic cancer 4) is a key factor in TGF-β signaling and a tumor suppressor frequently mutated in pancreatic and colon cancers.
  • TGF-β signaling can promote cancer progression via genes like Snail and MMPs, suggesting Smad4 loss may confer a survival advantage.
  • Understanding Smad4's role beyond TGF-β signaling is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the novel role of Smad4 in serum-deprivation-induced apoptosis.
  • To elucidate the molecular mechanisms by which Smad4 regulates cell death.
  • To determine if Smad4's tumor suppressive function is independent of TGF-β signaling.

Main Methods:

  • Western blotting to assess protein expression (Smad4, PUMA, PAK1, Siah-1, pVHL).
  • Cell viability assays under serum deprivation conditions.
  • Analysis of Smad4-expressed cancer tissues.

Main Results:

  • Serum deprivation increases Smad4 expression, inducing p53-independent PUMA expression and apoptosis.
  • Smad4-deficient cells exhibit resistance to serum starvation.
  • Smad4 suppresses PAK1, leading to PUMA stabilization; Siah-1 and pVHL are involved in this pathway.
  • Smad4-expressed cancer tissues show elevated PAK1 and support the Smad4-PUMA-PAK1 axis in cell death induction.

Conclusions:

  • Loss of Smad4 confers resistance to serum-deprivation-induced apoptosis, indicating a TGF-β-independent tumor suppressive function.
  • Smad4 regulates cell death through the suppression of PAK1 and subsequent PUMA stabilization.
  • Targeting the Smad4-PUMA-PAK1 pathway may offer new therapeutic strategies for cancers with Smad4 loss.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...